Long-acting injection a shot in the arm for GSK's HIV business
August 15, 2018 at 04:14 AM EDT
A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the British drugmaker's key HIV business.